Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)
Authors:
- Laurent ArnouldLALaurent Arnould
- Pascal RogerPRPascal Roger
- Sophie BeauclairSBSophie Beauclair
- Frederique Penault-LlorcaFPFrederique Penault-Llorca
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 25 (5) , 675-682
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimensBMC Cancer, 2010
- Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patientsCancer Science, 2010
- Accurately Assessing HER-2/neu Status in Needle Core Biopsies of Breast Cancer Patients in the Era of Neoadjuvant Therapy: Emerging Questions and Considerations AddressedAmerican Journal of Surgical Pathology, 2010
- Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)Annals of Oncology, 2009
- The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancerThe American Journal of Surgery, 2009
- Evaluation of automated silver‐enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimensHistopathology, 2009
- Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) casesLaboratory Investigation, 2008
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Preoperative Profiling of Symptomatic Breast Cancer by Diagnostic Core BiopsyAnnals of Surgical Oncology, 2006
- Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerWiener klinische Wochenschrift, 2004